CommunityRx-Kidney Health
- Chronic Kidney Disease (Stages 1-4)
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- University of North Carolina, Chapel Hill
- Enrolment target
- 634
- Started
- 13 April 2026
- Main results due
- June 2028
- Study sites
- 1
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Diagnosis of chronic kidney disease defined as ≥1 ICD-10 CKD codes (excluding end-stage kidney disease) or CKD biomarkers (estimated glomerular filtration rate ≤ 60 ml/min, albuminuria ≥30 mg/24h) * At least one clinic visit at Goshen Medical Center in 12 months before enrollment Exclusion Criteria: * Limited life expectancy (e.g., advanced cancer, end-stage liver disease, hospice) * Active cancer treatment * Living in a skilled nursing facility * Dementia/other significant cognitive impairment/inability to participate in the informed consent process
What this study is about
In the sponsor’s own words, from the registry.
In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina. Through a partnership among local primary care centers, community organizations, and researchers, CRx-K will strengthen rural care networks, improve CKD management, and enhance the well-being of rural communities.
Study sites(1)
Goshen Medical Center
Beulaville, North Carolina, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07237295. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me